Compromiso cardiovascular en la infección por el virus de inmunodeficiencia humana

Germán Valenzuela-Rodríguez

doi:10.47487/apcyccv.v4i1.269

Authors

Germán Valenzuela-Rodríguez Clínica Delgado-AUNA, Lima, Perú; Unidad de Revisiones Sistemáticas y Metaanálisis (URSIGET), Vicerrec- torado de Investigación, Universi- dad San Ignacio de Loyola, Lima, Perú. https://orcid.org/0000-0002-8595-9549

DOI:

https://doi.org/10.47487/apcyccv.v4i1.269

Keywords:

Human Immunodeficiency Virus, Cardiovascular Diseases, Acquired Immunodeficiency Syndrome

Abstract

Human immunodeficiency virus (HIV) infection was associated with increased morbidity and mortality, predominantly for opportunistic infections, before using antiretroviral therapy. With this, patients have experienced increased survival and cardiovascular compromise too. The etiology of these clinical conditions could be related to the infection itself, adverse events associated with antiretroviral therapy, or adverse events produced by the combination with other drugs. Some of these conditions have an acute onset, and their rapid recognition is vital for a better prognosis.

Downloads

Download data is not yet available.

References

So-Armah K, Benjamin LA; Bloomfield GS, Feinstein MJ, Hsue P, Njuguna B, et al. HIV and cardiovascular disease. Lancet HIV. 2020;7:e279-e93. doi: 10.1016/S2352-3018(20)30036-9

Valenzuela G. Enfermedad cardiovascular asociada a la infección por el virus de inmunodeficiencia humana. Panorama mundial y contribuciones peruanas. Rev Soc Per Med Intern. 2005;18(2):23-30. doi: 10.36393/spmi.v18i2.243.

Ministerio de Salud, Centro Nacional de Epidemiología, Prevención y Control de Enfermedades. Situación epidemiológica del SIDA en el Perú. Lima: Minsa; 2021.

Valenzuela-Rodríguez G. Compromiso cardíaco en el síndrome de Inmunodeficiencia Adquirida. Estudio comparativo en 2 hospitales [Tesis para optar el grado de Magíster en Medicina]. Lima, Perú: Universidad Peruana Cayetano Heredia; 2004.

Valenzuela-Rodríguez G, Mezones-Holguín E, Mendo-Urbina F, Rodríguez-Morales AJ. Cardiovascular disease in human immunodeficiency virus-infection as a cause of hospitalization: a case-series in a General Hospital in Peru. Braz J Infect Dis. 2015;19(4):431-435. doi: 10.1016/j.bjid.2015.03.001.

Mishra RK. Cardiac emergencies in patients with HIV. Emerg Med Clin North Am. 2010;28(2):273-82. doi: 10.1016/j.emc.2010.01.005.

Kearney MT, Cottom JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations and management. Postgrad Med J. 2001;77:4-10. doi: 10.1136/ pmj.77.903.4.

Mc Carthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342(10):690-5. doi: 10.1056/NEJM200003093421003.

Golpe R, Fernandez-Infante B, Fernandez Rozas S. Primary pulmonary hypertension associated with human immunodeficiency virus infection. Postgrad Med J. 1998;74:400-4. doi: 10.1136/ pgmj.74.873.400.

Pellicelli AM, Barbaro G, Palmieri F, Girardi E, D’Ambrosio C, Rianda A, et al. Primary pulmonary hypertension in HIV disease: a systematic review. Angiology. 2001;52(1):31-41.

Pellicelli AM, Palmieri F, D’Ambrosio C, Rianda A, Boumis E, Girardi E, et al. Role of human immunodeficiency virus primary pulmonary hypertension. Case reports. Angiology. 1998;49(12):1005-11. doi: 10.1177/000331979804901206.

Basyal B, Jarrett H, Barnett CF. Pulmonary Hypertension in HIV. Can J Cardiol. 2019;35:288-298. doi: 10.1016/j.cjca.2019.01.005.

Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16(12):745- 759. doi: 10.1038/s41569-019-0219-9.

Sinha A, Feinstein MJ. Coronary Artery Disease Manifestations in HIV: What, How, and Why. Can J. Cardiol. 2019;35(3):270-279. doi: 10.1016/j.cjca.2018.11.029.

Fragkou PC, Moschopoulos CD, Dimopoulou D, Triantafyllidi H, Birmpa D, Benas B, et al. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives. Hellenic J Cardiol. 2023;S1109-9666(22)00187-7. doi: 10.1016/j. hjc.2022.12.013.

Feinsein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV. Circulation. 2019;140:e98-e124. doi: 10.1161/CIR.0000000000000695.

Lekakis K, Ikonomidis I. Cardiovascular complications of AIDS. Curr Opin Crit Care. 2010;16(5):408-12. doi: 10.1097/ MCC.0b013e32833e10a9.

Hsue PY, Waters DD. What a cardiologist needs to know about patients with human immunodeficiency virus infection. Circulation. 2005;112(25):3947-57. doi: 10.1161/CIRCULATIONAHA.105.546465.

Barbaro G, Fisher SD, Pellicelli AM, Lipshultz SE. The expanding role of the cardiologist in the care of HIV infected patients. Heart. 2001;86(4):365-7. doi: 10.1136/heart.86.4.365.

Barbaro G. Cardiovascular manifestations of HIV infection. Circulation. 2002;106:1420-5. doi: 10.1161/01.cir.0000031704.78200.59.

Barbaro G, Fisher SD; Lipshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis. 2001;1(2):115-124. doi: 10.1016/S1473-3099(01)00067-6.

Barbaro G, Klatt EC. HIV infection and the cardiovascular system. AIDS Rev. 2002;4(2):93-103.

Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha- Gonçalves F, Lecour H. Pericardial involvement in human immunodeficiency virus infection. Chest. 1999;115(2):418-22. doi: 10.1378/chest.115.2.418.

Gouny P, Lancelin C, Girard PM, Hocquet-Cheynel C, Rozembaum W, Nussaume O. Pericardial effusion and AIDS: benefits of surgical drainage. Eur J Cardiothorac Surg. 1998;13(2):165-9. doi: 10.1016/ s1010-7940(97)00316-3.

Marco CA, Rothman RE. HIV infection and complications in emergency medicine. Emerg Med Clin North Am. 2008;26(2):367-87.

Barbaro G. HIV-associated cardiovascular complications: a new challenge for emergency physicians. Am J Emerg Med. 2001;19:566- 74. doi: 10.1016/j.emc.2008.01.001.

Bogorodskaya M, Chow FC, Triant VA. Stroke in HIV. Can J Cardiol. 2019;35(3):280-287. doi: 10.1016/j.cjca.2018.11.032.

So-Armah K, Freiberg MS. HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations and Novel Biomarkers. Curr HIV/AIDS Rep. 2018;15(3):233-244. doi: 10.1007/s11904-018-0400-5.

Brouillette J, Cyr S, Fiset C. Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients with HIV Infection. Can J Cardiol. 2019;35:310-319. doi: 10.1016/j.cjca.2018.12.015.

Fisher SD, Kanda BS, Miller TL, Lipshultz SE: Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV- infected patients. Am J Cardiovasc Drugs. 2011;11(6):383-94. doi: 10.2165/11594590-000000000-00000.

Venkat A, Piontkowsky DM, Cooney RR, Srivastava AK, Suares GA, Heidelberg CP. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy. Ann Emerg Med. 2008;52(3):274-285. doi: 10.1016/j.annemergmed.2008.01.324.

Pantazis N, Papastamopoulos V, Antoniadou A, Adamis G, Paparizos V, Metallidis S, et al. Changes in Body Mass Index after Initiation of Antiretroviral Treatment Differences by Class of Core Drug. Viruses. 2022;14(8):1677. doi: 10.3390/v14081677.

Gutierrez J, Alburqueque AAA, Falzon L. HIV infection as vascular risk: A systematic review of literature and meta-analysis. PLoS One. 2017;12(5):e0176686. doi: 10.1371/journal.pone.0176686.

Achhra AC, Lyass A, Borowsky L, Bogorodskaya M, Plutzky J, Massaro JM, et al. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations. Curr HIV/AIDS Rep. 2021;18(4):271- 279. doi: 10.1007/s11904-021-00567-w.

Karanika S, Karantanos T, Carneiro H, Assoumou SA. Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients. Cells. 2023;12(4):523. doi: 10.3390/cells12040523.

Valenzuela-Rodríguez G, Espinoza-Olortegui E. Identificación de los factores de riesgo cardiovascular por médicos infectólogos en los pacientes con infección por VIH de hospitales de referencia de Lima. Rev Soc Peru Med Interna. 2017;30(2):74-77. doi: 10.36393/spmi.v30i2.64.

Hidalgo JA, Florez A, Agurto C, Pinedo Y, Ayarza R, Rodríguez L, et al. Metabolic and Cardiovascular Comorbidities Among Clinically Stable HIV Patients on Long-Term ARV Therapy in Five Ambulatory Clinics in Lima-Callao, Peru. Open AIDS J. 2018(12):126-135. doi: 10.2174/1874613601812010126.